Professor Terry Nolan AO is an eminent public health researcher of international standing. His research has been principally in immunisation and clinical trials of new vaccines. He has over 220 publications including 205 in refereed journals and over $40m in grant funding. His research has made pivotal contributions enabling licensure of several vaccines now used worldwide, including HPV vaccine, penta and hexavalent combination paediatric vaccines, meningococcal vaccines (B, ACWY combinations), pandemic inactivated influenza vaccines (H1 and H5), live influenza vaccine, varicella and MMRV vaccines. He is a leader in research policy in Australia, and in the measurement of research impact.